CENTRE OF RESEARCH EXCELLENCE TO ACCELERATE STROKE TRIAL INNOVATION AND TRANSLATION - Profile, contacts and insights

CENTRE OF RESEARCH EXCELLENCE TO ACCELERATE STROKE TRIAL INNOVATION AND TRANSLATION

Who is CENTRE OF RESEARCH EXCELLENCE TO ACCELERATE STROKE TRIAL INNOVATION AND TRANSLATION?

The CRE will bring together current societies, organisations, and networks, as well as people with lived experience of stroke, in a collaborative platform designed to strengthen stroke research. The Stroke Trials CRE is uniquely positioned to bring together clinicians, consumer groups and represen...See more

Industry & Specialities

Government Administration

Healthcare

Countries of Operation

Australia

Headquarters:

Australia

Company Type:

SME

Company size:

11-50 Employees

Year Founded:

2023 (3 years)

Address:

176 HAWKESBURY RD; WESTMEAD, NEW SOUTH WALES 2145, AU

The largest company and people database for SEA & ANZ

Employees by Department

The Rest (1)
Total (1)

Key Decision Makers

Daniel Revesz

Research Assistant

Employees by Seniority

C-level

0employees

Senior

0employees

Non-managers

1employees

Financials

LOW

spending power

Funding Status

Private

Associated Legal Entities

0 entities

Ready to get started?

Start benefiting from our free-to-use platform today

Discover More Companies

Lookalike companies

Similar industry

Featured Lists

Fast Growing SMEs
Companies with Recent Funding > 100K
Companies with High Spending Power
MNCs / Large Enterprises in Singapore

Frequently Asked Questions (FAQ)

How long has CENTRE OF RESEARCH EXCELLENCE TO ACCELERATE STROKE TRIAL INNOVATION AND TRANSLATION been operating for?
What is the funding status of CENTRE OF RESEARCH EXCELLENCE TO ACCELERATE STROKE TRIAL INNOVATION AND TRANSLATION?
Where is CENTRE OF RESEARCH EXCELLENCE TO ACCELERATE STROKE TRIAL INNOVATION AND TRANSLATION's headquarter?
What CENTRE OF RESEARCH EXCELLENCE TO ACCELERATE STROKE TRIAL INNOVATION AND TRANSLATION's spending power?
Does CENTRE OF RESEARCH EXCELLENCE TO ACCELERATE STROKE TRIAL INNOVATION AND TRANSLATION have a presence in the domain it operates in?